Ann T. Farrell

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

Alexandra H. Filipovich, Daniel J. Weisdorf, Steven Z. Pavletic et al. · Biology of Blood and Marrow Transplantation · 2005 · 3.5K citations

Medicine, Pathology, Diagnostic Pathology +12

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Robert Q. Le, Liang Li, Weishi Yuan et al. · The Oncologist · 2018 · 882 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Z. Pavletic, Paul J. Martin, Stephanie J. Lee et al. · Biology of Blood and Marrow Transplantation · 2006 · 565 citations · Full text

Life Sciences, Immunology, Clinical Immunology +12

Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors

Martin H. Cohen, Ann T. Farrell, Robert Justice et al. · The Oncologist · 2009 · 429 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

FDA Approval: Blinatumomab

Donna Przepiorka, Chia‐Wen Ko, Albert Deisseroth et al. · Clinical Cancer Research · 2015 · 364 citations

Medicine, Hematology, Oncology +17